Rhenman & Partners Asset Management AB
Position in A — Agilent Technologies, Inc.
CIK 1599882
Stockholm, V7
Position in A
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,962,250
+$7,112,750 QoQ
Shares Held
75,000
+200.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#219
of 1,120 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $92,380,973 across 7 Diagnostics & Research names. A ranks #6 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
115,000 | $17,253,450 | |
| 2 | NTRA |
Natera, Inc.
|
61,050 | $16,572,022 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
31,580 | $15,832,948 | |
| 4 | DHR |
Danaher Corp /De/
|
80,252 | $15,286,400 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
57,200 | $12,972,388 | |
| 6 | A |
Agilent Technologies, Inc.
This page
|
75,000 | $9,962,250 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
8,500 | $4,501,515 |
All Filings in A
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,962,250 | 75,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,849,500 | 25,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,721,400 | 20,000 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||